{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:36:16Z","timestamp":1787726176038,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10014-015-0217-5","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T14:07:02Z","timestamp":1426342022000},"page":"202-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The density of microvessels positive for Wilms\u2019 tumour-1 protein (WT-1) is an independent predictor of recurrence risk in meningiomas"],"prefix":"10.1007","volume":"32","author":[{"given":"Valeria","family":"Barresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Caffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Vitarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/343774a0","volume":"343","author":"MP Gessler","year":"1990","unstructured":"Gessler MP, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletions in Wilms\u2019 Tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774\u2013778","journal-title":"Nature"},{"key":"217_CR2","first-page":"1167","volume":"8","author":"Y Miyoshi","year":"2002","unstructured":"Miyoshi Y, Ando A, Egawa C et al (2002) High expression of Wilms\u2019 Tumour suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8:1167\u20131171","journal-title":"Clin Cancer Res"},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1349-7006.2003.tb01507.x","volume":"94","author":"Y Oji","year":"2003","unstructured":"Oji Y, Yamamoto H, Nomura M et al (2003) Overexpression of the Wilms\u2019 Tumour gene WT1 in colorectal adenocarcinoma. Cancer Sci 94:712\u2013717","journal-title":"Cancer Sci"},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02482185","volume":"21","author":"Y Nakahara","year":"2004","unstructured":"Nakahara Y, Okamoto H, Mineta T, Tabuchi K (2004) Expression of the Wilms\u2019 Tumour gene product WT1 in glioblastomas and medulloblastomas. Brain Tumour Pathol 21:113\u2013116","journal-title":"Brain Tumour Pathol"},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1349-7006.2004.tb02188.x","volume":"95","author":"Y Oji","year":"2004","unstructured":"Oji Y, Suzuki T, Nakano Y, Maruno M et al (2004) Overexpression of the Wilms\u2019 Tumour gene WT1 in primary astrocytic tumours. Cancer Sci 95:822\u2013827","journal-title":"Cancer Sci"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1750-3639.2008.00127.x","volume":"18","author":"J Schittenhelm","year":"2008","unstructured":"Schittenhelm J, Mittelbronn M, Nguyen TD, Meyermann R, Beschorner R (2008) WT1 expression distinguishes astrocytic tumour cells from normal and reactive astrocytes. Brain Pathol 18:344\u2013353","journal-title":"Brain Pathol"},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2990.2008.00957.x","volume":"35","author":"J Schittenhelm","year":"2009","unstructured":"Schittenhelm J, Beschorner R, Simon P et al (2009) Diagnostic value of WT1 in neuroepithelial tumours. Neuropathol Appl Neurobiol 35:69\u201381","journal-title":"Neuropathol Appl Neurobiol"},{"key":"217_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/CBM-2010-0149","volume":"7","author":"J Schittenhelm","year":"2010","unstructured":"Schittenhelm J, Thiericke J, Nagel C, Meyermann R, Beschorner R (2010) WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade of malignancy. Cancer Biomark 7:73\u201377","journal-title":"Cancer Biomark"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/sj.onc.1208345","volume":"24","author":"M Tuna","year":"2005","unstructured":"Tuna M, Chavez-Reyes A, Tari AM (2005) HER2\/neu increases the expression of Wilms\u2019 Tumour 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 24:1648\u20131652","journal-title":"Oncogene"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.18632\/oncotarget.1610","volume":"5","author":"V Katuri","year":"2014","unstructured":"Katuri V, Gerber S, Qiu X et al (2014) WT1 regulates angiogenesis in Ewing Sarcoma. Oncotarget 5:2436\u20132449","journal-title":"Oncotarget"},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1093\/hmg\/ddl196","volume":"15","author":"P Hohenstein","year":"2006","unstructured":"Hohenstein P, Hastie ND (2006) The many facets of the Wilms\u2019 Tumour gene, WT1. Hum Mol Genet 15:R196\u2013R201","journal-title":"Hum Mol Genet"},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/1078-0432.CCR-13-2756","volume":"20","author":"N Veomett","year":"2014","unstructured":"Veomett N, Dao T, Liu H, Xiang J et al (2014) Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clin Cancer Res 20:4036\u20134046","journal-title":"Clin Cancer Res"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","volume":"15","author":"MA Cheever","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS et al (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15:5323\u20135337","journal-title":"Clin Cancer Res"},{"key":"217_CR14","volume-title":"WHO classification of tumours of the central nervous system","author":"A Perry","year":"2007","unstructured":"Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22\u201339","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"217_CR16","first-page":"1029","volume":"49","author":"SL Stafford","year":"2001","unstructured":"Stafford SL, Pollock BE, Foote RL et al (2001) Meningioma radiosurgery: tumour control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029\u20131037","journal-title":"Neurosurgery"},{"key":"217_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/neuonc\/not007","volume":"15","author":"K Iwami","year":"2013","unstructured":"Iwami K, Natsume A, Ohno M et al (2013) Adoptive transfer of genetically modified Wilms\u2019 Tumor 1-specific T cells in a novel malignant skull base meningioma model. Neuro Oncol 15:747\u2013758","journal-title":"Neuro Oncol"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12253-011-9456-x","volume":"18","author":"A Singh","year":"2012","unstructured":"Singh A, Mishra AK, Ylaya K, Hewitt SM, Sharma KC, Saxena S (2012) Wilms Tumour-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma. Pathol Oncol Res 18:383\u2013389","journal-title":"Pathol Oncol Res"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"968794","DOI":"10.1155\/2014\/968794","volume":"2014","author":"E Abdelzaher","year":"2014","unstructured":"Abdelzaher E, Abdallah DM (2014) Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int 2014:968794","journal-title":"Biomed Res Int"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.18632\/oncotarget.1610","volume":"5","author":"V Katuri","year":"2014","unstructured":"Katuri V, Gerber S, Qiu X et al (2014) WT1 regulates angiogenesis in Ewing Sarcoma. Oncotarget 5:2436\u20132449","journal-title":"Oncotarget"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-007-0251-4","volume":"114","author":"V Barresi","year":"2007","unstructured":"Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147\u2013156","journal-title":"Acta Neuropathol"},{"key":"217_CR22","first-page":"485","volume":"20","author":"V Barresi","year":"2008","unstructured":"Barresi V, Alafaci C, Salpietro F, Tuccari G (2008) Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade; proliferation or microvessel density? Oncol Rep 20:485\u2013492","journal-title":"Oncol Rep"},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00428-009-0757-3","volume":"454","author":"V Barresi","year":"2009","unstructured":"Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 454:563\u2013571","journal-title":"Virchows Arch"},{"key":"217_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10014-010-0012-2","volume":"28","author":"V Barresi","year":"2011","unstructured":"Barresi V (2011) Angiogenesis in meningiomas. Brain Tumour Pathol 28:99\u2013106","journal-title":"Brain Tumour Pathol"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-013-1117-3","volume":"113","author":"V Barresi","year":"2013","unstructured":"Barresi V, Branca G, Granata F, Alafaci C, Caffo M, Tuccari G (2013) Embolized meningiomas, risk of overgrading and neo-angiogenesis. J Neurooncol 113:207\u2013219","journal-title":"J Neurooncol"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.3390\/ijms15045663","volume":"15","author":"V Barresi","year":"2014","unstructured":"Barresi V, Branca G, Caffo M et al (2014) Immuno-expression of endoglin and smooth muscle actin in the vessels of brain metastases. Is there a rational for anti-angiogenic therapy? Int J Mol Sci 15:5663\u20135679","journal-title":"Int J Mol Sci"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1789.2010.01105.x","volume":"30","author":"V Barresi","year":"2010","unstructured":"Barresi V, Tuccari G (2010) Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathology 30:537\u2013546","journal-title":"Neuropathology"},{"key":"217_CR28","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Stafford SL, Scheithauer BW, Lohse CM, Wollan PC (1999) \u201cMalignancy\u201d in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046\u20132056","journal-title":"Cancer"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","volume":"117","author":"NS Goldstein","year":"2002","unstructured":"Goldstein NS, Uzieblo A (2002) WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 117:541\u2013545","journal-title":"Am J Clin Pathol"},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2008.08.032","volume":"111","author":"A Coosemans","year":"2008","unstructured":"Coosemans A, Moerman P, Verbist G et al (2008) Wilms\u2019 Tumour gene 1 (WT1) in endometrial carcinoma. Gynecol Oncol 111:502\u2013508","journal-title":"Gynecol Oncol"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2559.2008.03213.x","volume":"54","author":"A Coosemans","year":"2009","unstructured":"Coosemans A, Van Hove T, Verbist G et al (2009) Wilms\u2019 Tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours. Histopathology 54:384\u2013387","journal-title":"Histopathology"},{"key":"217_CR32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.acthis.2012.04.006","volume":"115","author":"R Parenti","year":"2013","unstructured":"Parenti R, Perris R, Vecchio GM et al (2013) Immunohistochemical expression of Wilms\u2019 Tumour protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem 115:70\u201375","journal-title":"Acta Histochem"},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00424-008-0621-3","volume":"458","author":"H Scholz","year":"2009","unstructured":"Scholz H, Wagner KD, Wagner N (2009) Role of the Wilms\u2019 Tumour transcription factor, WT1, in blood vessel formation. Pflugers Arch 458:315\u2013323","journal-title":"Pflugers Arch"},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1038\/sj.onc.1211044","volume":"27","author":"N Wagner","year":"2008","unstructured":"Wagner N, Michiels JF, Schedl A, Wagner KD (2008) The Wilms\u2019 Tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene 27:3662\u20133672","journal-title":"Oncogene"},{"key":"217_CR35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1096\/fj.02-1065fje","volume":"J17","author":"KD Wagner","year":"2003","unstructured":"Wagner KD, Wagner N, Wellmann S et al (2003) Oxygen-regulated expression of the Wilms\u2019 Tumour suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J17:1364\u20131366","journal-title":"FASEB"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-015-0217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0217-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:15:42Z","timestamp":1717794942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-015-0217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1007\/s10014-015-0217-5","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}